Stock VBIV VBI VACCINES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News VBI Vaccines Inc.

Equities

VBIV

CA91822J2020

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-15 pm EDT 		5-day change 1st Jan Change
0.58 USD 0.00% Intraday chart for VBI Vaccines Inc. -37.02% -1.28%
12:41pm North American Morning Briefing : Stock Futures -2- DJ
Apr. 08 North American Morning Briefing : Inflation Data, -2- DJ

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Stock Futures -2-
DJ
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BU
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BU
North American Morning Briefing : Inflation Data, -2-
DJ
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
BU
VBI Vaccines Inc. Presents Encouraging Early Tumor Response Data from Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
CI
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform - VBI Vaccines
AQ
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
BU
VBI Vaccines Inc. Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA- Launched eVLP Vaccine Platform
CI
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
AQ
North American Morning Briefing : Tech in Focus on -2-
DJ
North American Morning Briefing : Investors -2-
DJ
North American Morning Briefing : Stock Futures -2-
DJ
Brii Biosciences Announces Agreements To Acquire VBI Vaccines' IP Rights In BRII-179
AQ
Thinking about buying stock in Arena Group, Dunxin Financial Holdings, Nano-X Imaging, VBI Vaccines, or SuRo Capital?
PR
VBI Vaccines Sells Rights to Hepatitis B Vaccine to Brii Biosciences
MT
VBI Vaccines Inc. Enter into New License Agreement with Brii Biosciences
CI
VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences
BU
Brii Biosciences to Buy Rights to Hepatitis B Vaccine from VBI
MT
VBI Vaccines Inc. and VBI Cda Enters into a Forbearance Agreement with K2 HealthVentures LLC
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VBIV Stock
  4. News VBI Vaccines Inc.